In 2004, the International Agency for Research on Cancer (IARC) judged that there was sufficient evidence in humans that tobacco smoking causes cancers of the lung, larynx, oral cavity and pharynx, paranasal sinuses, oesophagus, stomach, pancreas, liver, kidney, ureter, bladder, uterine cervix and bone marrow (myeloid leukaemia; [@bib11]). At a recent expert review (to be published as IARC Monograph 100E), the list of cancers for which the evidence for tobacco smoking being causative was considered to be 'sufficient\' was updated to include cancers of the colon and rectum, and mucinous tumours of the ovary ([@bib19]).

In the 2004 evaluation, the IARC judged that there was sufficient evidence that involuntary smoking -- that is, exposure to second-hand or 'environmental\' tobacco smoke (ETS) -- causes lung cancer in humans ([@bib11]). In this monograph, the results of meta-analyses were reported, showing a statistically significant and consistent association between lung cancer risk in spouses of smokers and exposure to second-hand tobacco smoke from the spouse who smokes. The relative risk was 1.24 in women and 1.37 in men after controlling for some potential sources of bias and confounding. The excess risk increases with increasing exposure. For lung cancer in never smokers exposed to ETS at the workplace, the relative risks were 1.19 in women and 1.12 in men. For children exposed to smoke from their parents smoking, the evidence for an increased risk of lung cancer was less consistent.

The reported increases in risk of lung cancer from ETS exposure pertain to non-smokers (indeed, usually to persons who have never smoked). It would be impossible to directly quantify the tiny increment in risk that a smoker might suffer from exposure to another person\'s smoke (as well as his own). Thus, calculation of attributable fractions will be undertaken only for lung cancer cases in never smokers. This makes sense in that the ultimate aim is to estimate how much cancer is caused by smoking, and this comprises the cases caused by direct smoking and those caused by involuntary smoking in never smokers. Even if a theoretical estimate of the total effect of other persons\' smoking was made (including the incremental risk to current and past smokers), this latter component would have to be deducted from the total tobacco-attributable fraction, as involuntary smoking cannot occur without active smoking by others.

Tobacco smoking
===============

Methods
-------

The numbers and percentage of cancers caused by tobacco smoking are estimated using the method developed by [@bib17]. This is based on the assumption that tobacco smoking is overwhelmingly the most important cause of lung cancer, and that the incidence of this disease in the absence of smoking would be more or less the same in all populations, so that contemporary incidence (or mortality) rates from lung cancer simply reflect the cumulative exposure of a particular population to tobacco smoking. A set of data is required for the calculation, comprising, from the same population, incidence rates of lung cancer in persons who have never smoked and relative risks of different cancers in smokers relative to never smokers. Similar to [@bib17], we use the data from the follow-up during 1982--1988 of the American Cancer Society\'s second 'Cancer Prevention Study\' (CPS II; [@bib21]), the largest cohort study carried out until now, involving more than a million volunteers aged ⩾30 years at the time of enrolment in 1982 ([@bib8]; [@bib3]). Lung cancer incidence in never smokers has been estimated from the death rates in the CPS II study, for a slightly longer period of follow-up (1982--2002; [@bib22]; [Figure 1](#fig1){ref-type="fig"}).

The relative risks of death from different cancers during the follow-up period (1984--1988); and the sources are shown in [Table 1](#tbl1){ref-type="table"}. Most values listed here were those published in [@bib7]. For cancers of the colon and rectum, the values were those from the follow-up of the CPS II Nutrition Cohort to June 2005 ([@bib10]), in which the multivariate hazard ratios in current smokers were 1.24 in men and 1.30 in women. No data for the risk of mucinous carcinomas of the ovary in smokers have been published based on the CPS II cohort; the value used (2.1) was that from a meta-analysis published by [@bib15].

The first step is to calculate the number of lung cancer cases expected in the UK in the absence of smoking, by applying the age- and sex-specific never-smoker rates (in [Figure 1](#fig1){ref-type="fig"}) to the population of the UK in 2010. The number of cases attributable to smoking (and the attributable fraction) is then derived by subtracting the expected cases from the number actually observed in 2010. The results are shown in [Table 2](#tbl2){ref-type="table"}.

For the other cancers, the rates in non-smokers are not known, and thus the usual formula for calculating the population attributable fraction (PAF) is used: where *P*~e~ is the prevalence of exposure and *r* is the relative risk in smokers.

Using the attributable fractions of lung cancer, already estimated ([Table 2](#tbl2){ref-type="table"}) by age group and sex, and the relative risks for lung cancer in smokers from the American cohort ([Table 1](#tbl1){ref-type="table"}), the above formula enables calculation of *P*~e~ for each age/sex group. This may be thought of as the 'notional\' prevalence of smoking (ever *vs* never) in the UK population -- more specifically, the prevalence that would have been necessary in the UK population to produce the observed incidence rates if the relative risks of the CPS II study had pertained.

Finally, we use the same formula, the values of prevalence (*P*~e~) and the relative risks for the other cancers ([Table 1](#tbl1){ref-type="table"}) to estimate their PAF and, consequently, the numbers of cases attributable to smoking.

'Notional prevalence\' (*P*~e~) is an artificial concept that may be quite different from the true prevalence, depending on how different the past experience of tobacco smoking in the population under study was from that in the volunteers of the CPS II study. It can, in fact, even be \>1 if a particular age/sex/population cohort has a higher prevalence of smoking and/or a higher relative risk of lung cancer than the CPS II subjects.

Results
-------

For lung cancer ([Table 2](#tbl2){ref-type="table"}), the results suggest that about 85% of the lung cancer cases in men are attributable to smoking, and in women the percentage is 80%.

[Table 3](#tbl3){ref-type="table"} shows the estimated numbers of cancer cases at sites other than the lung, and the fractions due to tobacco smoking. (No estimate is made for cancers of the paranasal sinuses, owing to the lack of relevant data on the risk of tobacco smoking; the number of cases concerned would be very few: the total number of cases registered in England in 2008 was 125.)

Taking these figures together, we can estimate that, in total, 36 102 (22.8% of the total) cancers in men and 23 722 (15.2% of the total) in women are attributable to smoking tobacco (currently, or in the past).

Discussion
----------

The method of estimation developed by [@bib17], [@bib16]) is based on the assumption that the excess mortality (or incidence) from lung cancer, above that which would have been observed in persons who have never smoked, is the result of smoking (past and current). Thus, the attributable fraction of lung cancer can be estimated as and used to estimate the attributable fractions of other cancers. It should be noted that it is of no consequence that the data set used for estimates of PAF in 2010 is derived from study results pertaining to the period 1984--1988, so long as the two components (mortality/incidence of lung cancer in non-smokers, and relative risks of different cancers in smokers *vs* never-smokers) derive from the same population. On the other hand, it is important that the non-smoker rates observed in the US volunteers in 1984--1988 are appropriate to the UK population in 2010. The only large cohort study in the UK was for British Doctors -- almost all of them being men. The US CPS II non-smoker rates predicted 19.03 lung cancer deaths in 40 years of follow-up, *vs* 19 actually observed ([@bib16]), confirming that non-smoker rates in the UK are likely to be very similar to those in the US CPS II cohort.

The main advantage of the Peto method is that it does not require detailed information of the current relative risks of different cancers in relation to smoking history in the UK population. The risk of tobacco smoking depends on cumulative exposure to carcinogens in tobacco smoke, and therefore varies with the amount smoked, duration of smoking and time since cessation (in ex-smokers), as well as with the type of cigarette smoked. Factors such as these differ between countries, and over time, and thus one cannot be sure that relative risks taken from studies in different populations (geographic or temporal) would be appropriate for the UK in 2010. In the USA, the relative risk of lung cancer in current smokers (relative to never smokers) was 11.5 in men and 2.7 in women in the Cancer Prevention Study I (CPS I) conducted by the American Cancer Society during 1959--1965, whereas it was 23.3 in men and 12.7 in women in CPS II ([@bib25]). In the British Doctors study, the relative risk in current smokers rose from 15.5 during 1951--1971 to 18.5 during 1971--1991 ([@bib6]). In fact, one might have expected the switch to cigarettes delivering low tar to have reduced the hazard of lung cancer, but this effect is being offset by the 'maturing\' of the smoking epidemic, and thus smokers still alive in more recent years have had a longer history of regular consumption of cigarettes than men of the same ages would have had during the 1950s and 1960s. Another factor that may be important in the maturing of the epidemic (but which is impossible to quantify) is a change in the way cigarettes have been smoked in recent decades. The minority of doctors who continued to smoke cigarettes in the latter half of the study may have tended to be those who smoked them in a way different from that of the greater number who had stopped smoking them earlier.

Using the ratio of mortality rates from lung cancer in never, former and current smokers after the 50-year follow-up of British doctors ([@bib5]), and the prevalence of smoking among British men in 2008 (22% current smokers, 30% ex-smokers; [@bib9]), the estimate of the PAF of lung cancer is 80%. This is somewhat lower than the 85% estimate of the current analysis, and that of [@bib18], who, using essentially the same methodology, estimated that 88% of lung cancer deaths in men in the UK in the year 2007 were due to smoking, and 84% of deaths in women. The reason, as noted above, is that the relative risks observed in British doctors are unlikely to be the same as the averages for the UK population in 2010.

Environmental tobacco smoke (ETS)
=================================

Methods
-------

Estimation of the fraction of cancer caused by exposure to ETS in lifelong non-smokers uses the traditional method for attributable fractions, incorporating estimates of relative risk (of exposure to tobacco smoke) and the prevalence of such exposure among never smokers. The formula for calculating PAF is as follows: where *P*~e~ is the prevalence of exposure and *r* is the relative risk of lung cancer in those exposed to ETS. The attributable fraction is applied to the number of lung cancer cases estimated to occur among never smokers. From the section on tobacco smoking, this was estimated to be 6819 (3262 in men and 3557 in women) in the UK in 2010 ([Table 2](#tbl2){ref-type="table"}).

We may estimate two components: Cases of lung cancer (in never smokers) caused by domestic exposure to ETS.Cases of lung cancer (in never smokers) caused by exposure to ETS in the workplace.

The relative risks from the [@bib11] meta-analyses, described in the Introduction, are used ([Table 4](#tbl4){ref-type="table"}).

*Exposure to ETS at home* Most studies investigate the risk of lung cancer in lifelong non-smokers (never-smokers) living with a smoking spouse, and it was on a meta-analysis of such studies that the estimated relative risks in the IARC monograph were based. There appear to be no survey data upon which one can estimate the prevalence of such exposures in the UK. A range of approaches have been used by others, from using the exposure prevalence of control subjects in case--control studies ([@bib12]) to extrapolation from exposure of children to ETS at home ([@bib13]). [@bib23] estimate the exposure from spouse smoking based on the prevalence of smoking in men and women, and the probability that couples would be discordant for their smoking status. This seems to be the method most likely to yield exposures equivalent to those for which relative risks have been estimated, as well as allowing estimates specific to the UK (which controls from case--control studies cannot). Using data from the General Household Survey for 2008, we may obtain the prevalence of current, ever or never smokers by age group, as well as the probability of being married or cohabiting currently or ever in the past. We use the 'aggregation factor\' of 3.0 proposed by [@bib26] to express the relative probability of couples being concordant for smoking status.

[Table 5](#tbl5){ref-type="table"} shows the percentage of the UK population who are currently married or cohabiting (column 1), and the percentage who have ever been married (or cohabiting; column 2), by age group. Column 3 shows the prevalence of current smokers, and column 4 the percentage of persons who have never smoked.

Under the assumption that couples are in the same broad age groups as those in the table, and that the 'aggregation factor\' described above is 3.0, we can estimate the percentage of never smokers who belong to the following categories: Currently living with a smoking partner (column 5)Currently living with a partner who has ever smoked (column 7)Has ever lived with a partner who was a smoker at some point of time (column 9).

The corresponding attributable fractions of lung cancers among never smokers are shown in columns 6, 8 and 10. They range from 2% of lung cancer cases in non-smoking men (due to their current partner\'s smoke) to 10.1% of lung cancers in non-smoking women, as a consequence of ever having had a partner who was a smoker at some point of time.

Although the relative risks derive from studies of non-smokers with current partners who smoked, the corresponding estimates of PAF in [Table 5](#tbl5){ref-type="table"} (column 6) are probably an underestimate, because of the following factors: They take account only of current partnerships, and it is likely that past partnerships with a smoker would have had some adverse effects, particularly when separation had occurred only recentlySome non-smoking partners may have quit relatively recently, and their past smoking would have had an adverse effectThere may be other members of the household smoking, even though the partner does not.

For these reasons, the attributable fractions in column 8 (based on non-smokers with a current partner who was ever a smoker) are taken as the relevant estimate for the UK population.

*Exposure to ETS at work* [@bib13] gives the prevalence of passive smoking at work as 11%, an estimate that probably derives from the survey commissioned by ASH in April 1999, which revealed that approximately 3 million people in the UK are regularly exposed to ETS at work ([@bib1]). There are otherwise very few data on workplace exposure to ETS in the UK. [@bib4], in a small sample derived from participants in the fourth Scottish MONICA survey of 1995, found that any (regular) exposure of adults aged 25--64 years to environmental tobacco smoke at work was 68.1% for men and 57.5% for women (of which 21.5% of men and 17.4% of women classified such exposure as 'some\' or 'a lot\'). The EPIC study collected data on exposure to ETS at the time of recruitment among 123 000 non-smokers from 11 centres (none of them in UK) during 1993--1998, 78% of whom were women; 67% reported exposure at work ([@bib24]). The proportion of non-smoker controls in the multi-centre European case--control study of [@bib2] who reported ever being exposed to ETS at work was 71% in men and 47% in women.

It is difficult, based on such incomplete data, and the varying definition of 'exposure\', to decide an appropriate prevalence for the UK. On the basis of the average of the results from [@bib2], Chen *et al* (2001) and [@bib24], 71% for men and 53% for women, 8% of lung cancers in never-smoking men and 9% in women would be due to workplace exposure to ETS. With the much lower exposure estimate of Jamrozik (11%), the attributable fractions would be 1.3% and 2.0% in men and women, respectively.

Results
=======

Estimate of attributable fraction in lifelong non-smokers
---------------------------------------------------------

[Table 6](#tbl6){ref-type="table"} shows the final estimates of lung cancer attributable to ETS from the spouse, and at work, with the assumptions described above. With respect to combined exposure, it is assumed that the relative risks are simply multiplicative (no interaction). The exposures are assumed to be either independent of each other orcorrelated, in that individuals exposed at home are more likely to be exposed at work. In fact, the concordance between exposures at the two sites is rather weak: on the basis of the results among the control subjects in the study by [@bib2], the *κ* value is −0.005 for women and +0.05 for men.

In total, 14--15% of lung cancer cases among individuals who have never smoked are estimated to be due to exposure to ETS.

Discussion
==========

The estimate of the effect of exposure to spousal smoking is based on current (2008) data on the proportion of persons married or cohabiting, and an estimate of the likelihood that their current partner has ever smoked. The percentages are 17% for men (aged over 16) and 23% for women. Self-reported exposure to spousal smoke among controls in the multi-centre European case--control study of [@bib2] was reported as 12.8% for men and 62.7% for women -- but these are values for those ever exposed, which were used in estimating the PAF in France ([@bib12]). In the EPIC study, 28.5% of non-smokers (78% women) from 11 centres in Europe (not UK) reported ETS exposure (probably at the time of recruitment) at home ([@bib24]). The estimates of [@bib13] − 37% of adults under 65 exposed at home -- are clearly inappropriate, as they relate to exposure of children to smoke at home from either parent. In the UK, [@bib14], in a sample of adults from the general population of England in 1994 and 1996, found that among 9556 married or cohabiting non-smokers 14.5% had a partner who was a current cigarette smoker. This is similar to the indirect estimate of 17% (men) and 23% (women) who would be expected to have a smoking partner, based on the current prevalence in 2008, and an aggregation factor of 3, on which the result in [Table 5](#tbl5){ref-type="table"} is based. Smoking prevalence has declined over time, and exposure to smoke from a smoking spouse would have been greater in the past (among individuals developing lung cancer in 2010), especially for women, as smoking has declined among men much more than among women. However, as the estimate is based on the probability of the current partner ever having been a smoker, any bias will be small.

The estimate of the role of exposure to ETS in the workplace uses the relative risks from the meta-analysis of case--control studies conducted by [@bib11]. A somewhat more recent meta-analysis of 22 studies ([@bib20]) suggested a similar magnitude of relative risk (1.24). The definition of 'exposure\' in the studies included in these analyses varies, and, in any case, estimates of the PAF depend on the prevalence of workplace exposure to ETS in the UK population, for which there are no representative data.

A previous estimate for deaths attributable to passive smoking in the UK was made by [@bib13]. The results are rather different from those obtained here -- 1372 deaths from lung cancer due to exposure at home and 160 due to exposure at work. The reasons for this are different assumptions concerning prevalence of exposure (as mentioned above) and relative risk, and the attribution of no lung cancer deaths after the age of 64 years to workplace exposures. What is more, Jamrozik estimates lung cancer deaths attributable to passive smoking in the whole population -- including among current and past smokers; as noted in the introduction, this is illogical, as such deaths would not occur among non-smokers if no one smoked.

Summary
=======

[Table 7](#tbl7){ref-type="table"} summarizes the findings with respect to lung cancer and exposure to tobacco smoke. In total, 34 599 cases of lung cancer in the UK (86% of the total) were due to exposure to tobacco smoke in 2010, the great majority of which (97.4%) are due to active smoking (current or in the past). The figures for men are 87% cases due to exposure to tobacco (of which 97.7% were due to smoking), and for women 84% cases due to exposure to tobacco (of which 96.2% were due to smoking).

[Table 8](#tbl8){ref-type="table"} shows the final summary of the estimate of tobacco-attributable cancer in the UK. In total, the estimate is of 60 837 cancer cases (19.4% of all new cancer cases) attributable to tobacco: 36 537 (23.0%) of cancers in men and 24 300 (15.6%) of cancers in women.
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###### Estimated relative risks (RR) for current smokers aged ⩾35 compared with never-smokers

  **Cancer**                                           **Male**   **Female**
  ---------------------------------------------------- ---------- ------------
  Lung[a](#t1-fn1){ref-type="fn"}                      21.3       12.5
  Oral cavity and pharynx[b](#t1-fn2){ref-type="fn"}   10.9       5.1
  Oesophagus[b](#t1-fn2){ref-type="fn"}                6.8        7.8
  Stomach[a](#t1-fn1){ref-type="fn"}                   2.2        1.5
  Liver[a](#t1-fn1){ref-type="fn"}                     2.3        1.5
  Pancreas[a](#t1-fn1){ref-type="fn"}                  2.2        2.2
  Colon--rectum[c](#t1-fn3){ref-type="fn"}             1.24       1.30
  Larynx[b](#t1-fn2){ref-type="fn"}                    14.6       13.0
  Cervix[a](#t1-fn1){ref-type="fn"}                    ---        1.5
  Ovary (mucinous)[d](#t1-fn4){ref-type="fn"}          ---        2.1
  Urinary bladder[a](#t1-fn1){ref-type="fn"}           3.0        2.4
  Kidney and renal pelvis[a](#t1-fn1){ref-type="fn"}   2.5        1.5
  Acute myeloid leukaemia[a](#t1-fn1){ref-type="fn"}   1.9        1.2

From [@bib7].

From [@bib25].

From [@bib10].

From [@bib15].

###### Cases of lung cancer attributable to smoking, by sex and age group (UK, 2010)

  **Age group (years)**   **Population (thousands)**   **Rates observed**   **Cases observed**   **Rates expected**[a](#t2-fn2){ref-type="fn"}   **Cases expected**[a](#t2-fn2){ref-type="fn"}   **Excess attributable cases**   **PAF (%)**
  ----------------------- ---------------------------- -------------------- -------------------- ----------------------------------------------- ----------------------------------------------- ------------------------------- -------------
  *Males*                                                                                                                                                                                                                        
   0--14                  5548                         0.0                  1                    0.0                                             0                                               1                               0
   15--34                 8365                         0.5                  38                   0.5                                             38                                              0                               0
   35--44                 4387                         4.9                  215                  2.9                                             128                                             87                              40
   45--54                 4202                         27.1                 1138                 6.0                                             252                                             886                             78
   55--64                 3580                         116.9                4184                 14.3                                            513                                             3705                            89
   ⩾65                    4526                         368.9                16 697               51.5                                            2331                                            14 366                          86
   Total                  30 609                       72.8                 22 273               ---                                             3262                                            19 011                          85
                                                                                                                                                                                                                                  
  *Females*                                                                                                                                                                                                                      
   0--14                  5292                         0.0                  2                    0.0                                             0                                               2                               0
   15--34                 8048                         0.4                  42                   0.5                                             42                                              0                               0
   35--44                 4452                         4.5                  224                  3.8                                             168                                             56                              25
   45--54                 4331                         26.7                 1088                 7.4                                             320                                             768                             71
   55--64                 3731                         85.3                 3441                 14.9                                            556                                             2885                            84
   ⩾65                    5759                         218.0                13 335               42.9                                            2471                                            10 864                          81
   Total                  31 614                       53.1                 18 132               ---                                             3557                                            14 575                          80

Abbreviations: PAF=population-attributable fraction.

Expected in a population that had never smoked.

###### Other cancers: cases attributable to smoking in 2010

              **Cases attributable to smoking for specific cancers**                                                                                                                                                                                                                                
  ----------- -------------------------------------------------------- ------ ---- ------ ------ ---- ------ ------ ---- ------ ------ ---- ------ ------ ---- -------- -------- ---- ------ ----- ---- ------ ------ ----- ------ ------ ----- ------ ------ ---- ------ ------ ---- ------ ------ ----
  *Males*                                                                                                                                                                                                                                                                                           
   0--14      5                                                        5      0    0      0      0    0      0      0    15     15     0    0      0      0    1        1        0    0      0     0    ---    ---    ---   ---    ---    ---   1      1      0    54     54     0    41     41     0
   15--34     77                                                       77     0    12     12     0    14     14     0    23     23     0    9      9      0    163      163      0    2      2     0    ---    ---    ---   ---    ---    ---   8      8      0    37     37     0    97     97     0
   35--44     244                                                      183    25   86     72     16   82     79     4    43     41     4    67     64     4    397      394      1    35     24    31   ---    ---    ---   ---    ---    ---   58     54     6    206    196    5    89     86     3
   45--54     902                                                      332    63   469    234    50   251    208    17   166    136    18   278    230    17   1436     1379     4    195    58    70   ---    ---    ---   ---    ---    ---   235    175    26   612    486    21   150    130    13
   55--64     1458                                                     325    78   1308   430    67   677    476    30   493    338    31   818    575    30   4129     3807     8    535    92    83   ---    ---    ---   ---    ---    ---   961    564    41   1295   847    35   348    264    24
   ⩾65        1887                                                     471    75   3836   1389   64   3443   2524   27   1530   1097   28   2910   2133   27   15 999   14 912   7    1035   202   81   ---    ---    ---   ---    ---    ---   5448   3390   38   3493   2400   31   1321   1038   21
   Total      4573                                                     1393   70   5711   2137   63   4467   3300   26   2270   1650   27   4082   3011   26   22 125   20 656   7    1802   378   79   ---    ---    ---   ---    ---    ---   6711   4191   38   5697   4020   29   2046   1656   19
                                                                                                                                                                                                                                                                                                     
  *Females*                                                                                                                                                                                                                                                                                         
   0--14      6                                                        6      0    0      0      0    0      0      0    18     18     0    0      0      0    2        2        0    0      0     0    0      0      0     12     12     0     1      1      0    57     57     0    43     43     0
   15--34     75                                                       75     0    5      5      0    29     29     0    12     12     0    12     12     0    164      164      0    2      2     0    739    739    0     273    273    0     6      6      0    37     37     0    86     86     0
   35--44     131                                                      117    11   27     23     16   64     63     1    29     29     1    53     51     3    402      399      1    12     9     26   679    669    1     438    435    1     31     30     4    110    108    1    90     89     1
   45--54     354                                                      191    46   147    61     59   129    117    9    70     64     9    221    177    20   1230     1158     6    53     15    71   411    372    9     926    901    3     104    80     23   298    270    9    142    136    4
   55--64     593                                                      208    65   398    98     75   287    234    18   199    163    18   633    411    35   2755     2427     12   105    16    84   317    259    18    1506   1451   4     303    186    39   639    521    18   210    193    8
   ⩾65        1196                                                     466    61   2240   622    72   2067   1735   16   969    813    16   3361   2304   31   13 233   11 871   10   210    38    82   547    459    16    3665   3571   3     2126   1385   35   2223   1866   16   1025   952    7
   Total      2355                                                     1063   55   2817   808    71   2576   2178   15   1298   1099   15   4280   2955   31   17 786   16 020   10   382    80    79   2693   2498   7     6820   6643   3     2571   1688   34   3364   2860   15   1596   1500   6

Abbreviations: Exp.=cases expected; Obs.=cases observed; PAF (%)=population-attributable fraction.

###### Relative risks of lung cancer from exposure to ETS (IARC, 2004)

                           **RR by sex**   
  ------------------------ --------------- ------
  At home (spouse)         1.37            1.24
  At work (occupational)   1.12            1.19

Abbreviations: ETS=environmental tobacco smoke; RR=relative risk.

###### Prevalence estimates of cohabitation with smoking partner among non-smokers in UK, and fraction of lung cancer cases attributable to cohabitation with a smoking partner

            **Cohabitation status of never-smokers (%)**[a](#t5-fn2){ref-type="fn"}   **Population smoking status (%)**[a](#t5-fn2){ref-type="fn"}   **Estimated prevalence of never-smokers cohabiting with smoking partner and lung cancer cases attributable to cohabitation with smoking partner (%)**[b](#t5-fn3){ref-type="fn"}                                    
  --------- ------------------------------------------------------------------------- -------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---- ---- ----- ---- ------ ---- ------
  *Men*                                                                                                                                                                                                                                                                                                                                                                  
   16--24   8                                                                         8                                                              24                                                                                                                                                                                 69   1    0.5   2    0.6    2    0.6
   25--34   61                                                                        63                                                             30                                                                                                                                                                                 53   10   3.5   19   6.4    19   6.6
   35--44   77                                                                        82                                                             24                                                                                                                                                                                 51   11   3.8   25   8.3    26   8.8
   45--54   77                                                                        88                                                             24                                                                                                                                                                                 48   11   3.8   24   8.1    27   9.1
   55--64   79                                                                        93                                                             18                                                                                                                                                                                 41   7    2.5   16   5.6    19   6.5
   65--74   77                                                                        94                                                             13                                                                                                                                                                                 37   4    1.3   20   6.9    25   8.3
   ⩾75      60                                                                        93                                                             13                                                                                                                                                                                 37   8    2.8   14   5.0    22   7.5
   Total    63                                                                        72                                                             22                                                                                                                                                                                 49   6    2.0   17   6.0    20   6.8
                                                                                                                                                                                                                                                                                                                                                                          
  *Women*                                                                                                                                                                                                                                                                                                                                                                
   16--24   18                                                                        19                                                             26                                                                                                                                                                                 71   3    1.0   4    1.5    4    1.5
   25--34   68                                                                        72                                                             29                                                                                                                                                                                 57   12   4.1   24   8.1    25   8.6
   35--44   75                                                                        87                                                             25                                                                                                                                                                                 56   8    3.0   29   9.8    34   11.2
   45--54   75                                                                        93                                                             24                                                                                                                                                                                 57   10   3.4   31   10.3   38   12.4
   55--64   72                                                                        96                                                             22                                                                                                                                                                                 55   4    1.6   29   9.7    39   12.5
   65--74   63                                                                        96                                                             13                                                                                                                                                                                 56   7    2.5   32   10.7   50   15.5
   ⩾75      29                                                                        94                                                             13                                                                                                                                                                                 56   4    1.6   14   5.1    47   14.8
   Total    59                                                                        79                                                             21                                                                                                                                                                                 57   7    2.5   23   7.8    31   10.1

Abbreviations: PAF=population-attributable fraction.

Cohabitation status and population smoking status from General Lifestyle Survey 2008/ONS 2010 ([@bib9]).

Estimates are based on cohabitation status and population smoking status, and assume couples are in the same broad age groups as those in the table and the relative probability of couples being concordant for smoking status is 3.0 ([@bib26]).

###### Lung cancer cases attributable to exposure of non-smokers to ETS in UK in 2010

                           **Source of exposure**                                                                
  ------------------------ ------------------------ ------ ----- ------ ------ ----- ------ ------ ------ ------ ------
  *Men*                                                                                                          
   16--24                  0.01                     0      0     0.08   0      0     0      0       ---   0       ---
   25--34                  0.06                     38     2     0.08   38     3     38     5       13.7  5       12.9
   35--44                  0.08                     128    11    0.08   128    10    128    20      15.5  19      14.6
   45--54                  0.08                     252    20    0.08   252    20    252    38      15.3  36      14.4
   55--64                  0.06                     513    28    0.08   513    40    513    66      12.9  62      12.0
   65--74                  0.07                     854    59    0.08   854    67    854    121     14.2  114     13.3
   ⩾75                     0.05                     1478   74    0.08   1478   115   1478   183     12.4  170     11.5
  All ages                                          3262   195          3262   255   3262   434     ---   406     ---
  \% of total (all ages)                                   6.0                 7.8          13.3          12.4      
                                                                                                                    
  *Women*                                                                                                        
   16--24                  0.01                     0      0     0.09   0      0     0      0             0         
   25--34                  0.08                     42     3     0.09   42     4     42     7       16.5  7       15.6
   35--44                  0.10                     168    16    0.09   168    15    168    30      18.0  29      17.1
   45--54                  0.10                     320    33    0.09   320    29    320    59      18.5  56      17.6
   55--64                  0.10                     556    54    0.09   556    51    556    100     18.0  95      17.1
   65--74                  0.11                     822    88    0.09   822    75    822    155     18.9  148     18.0
   ⩾75                     0.05                     1649   84    0.09   1649   151   1649   227     13.8  212     12.8
  All ages                                          3557   279          3557   325   3557   578     ---   547     ---
  \% of total (all ages)                                   7.8                 9.1          16.3          15.4      
                                                                                                                    
  *Persons*                                                                                                      
   16--24                                           0      0            0      0     0      0             0         
   25--34                                           80     6            80     7     80     12      15.2  6       7.3
   35--44                                           296    27           296    25    296    50      16.9  27      9.1
   45--54                                           572    53           572    49    572    98      17.1  53      9.3
   55--64                                           1069   82           1069   91    1069   166     15.5  82      7.7
   65--74                                           1676   147          1676   142   1676   276     16.5  147     8.8
   ⩾75                                              3127   158          3127   266   3127   410     13.1  158     5.0
  All ages                                          6820   474          6820   580   6820   1013    ---   952     ---
  \% of total (all ages)                                   6.9                 8.5          14.8          14.0      

Abbreviations: ETS=environmental tobacco smoke; Obs.=observed cases; PAF=population-attributable fraction.

###### Cases of lung cancer attributable to tobacco, by sex and age group (UK 2010)

                                       **Total attributable cases**   
  ----------- -------- -------- ------ ------------------------------ ----
  *Males*                                                             
   0--34      38       0        5      5                              14
   35--44     215      87       20     107                            50
   45--54     1138     886      38     924                            81
   55--64     4184     3671     66     3737                           89
   ⩾65        16 697   14 366   305    14 671                         88
   Total      22 273   19 011   434    19 445                         87
                                                                       
  *Females*                                                           
   0--34      42       0        7      7                              17
   35--44     224      56       30     86                             39
   45--54     1088     768      59     827                            76
   55--64     3441     2885     100    2985                           87
   ⩾65        13 335   10 864   382    11 246                         84
   Total      18 132   14 575   578    15 153                         84
                                                                       
  *Persons*                                                           
   0--34      80       0        12     12                             15
   35--44     439      143      50     193                            44
   45--54     2226     1654     98     1752                           79
   55--64     7625     6556     166    6722                           88
   ⩾65        30 032   25 230   687    25 917                         86
   Total      40 405   33 586   1013   34 599                         86

Abbreviations: ETS=environmental tobacco smoke; PAF=population-attributable fraction.

###### Cancer cases caused by exposure to tobacco smoke (by smoking, or environmental), UK 2010

                             **Cases in UK, 2010**                   
  -------------------------- ----------------------- --------------- ------
  *Males*                                                            
   Lung                      22 273                  19 445 (87)     12.3
   Oral cavity and pharynx   4573                    3180 (70)       2.0
   Oesophagus                5711                    3574 (63)       2.3
   Stomach                   4467                    1167 (26)       0.7
   Liver                     2270                    620 (27)        0.4
   Pancreas                  4082                    1071 (26)       0.7
   Colon--rectum             22 125                  1469 (7)        0.9
   Larynx                    1802                    1424 (79)       0.9
   Cervix uteri              ---                     ---             ---
   Ovary                     ---                     ---             ---
   Bladder                   6711                    2520 (38)       1.6
   Kidney                    5697                    1677 (29)       1.1
   Leukaemia                 4639                    390 (8)         0.2
   All cancers               158 667                 36 537 (23.0)   23.0
                                                                      
  *Females*                                                          
   Lung                      18 132                  15 153 (84)     9.7
   Oral cavity and pharynx   2355                    1292 (55)       0.8
   Oesophagus                2817                    2009 (71)       1.3
   Stomach                   2576                    398 (15)        0.3
   Liver                     1298                    199 (15)        0.1
   Pancreas                  4280                    1325 (31)       0.9
   Colon--rectum             17 786                  1766 (10)       1.1
   Larynx                    382                     302 (79)        0.2
   Cervix uteri              2693                    195 (7)         0.1
   Ovary                     6820                    177 (3)         0.1
   Bladder                   2571                    883 (34)        0.6
   Kidney                    3364                    504 (15)        0.3
   Leukaemia                 3201                    96 (3)          0.1
   All cancers               155 584                 24 300 (15.6)   15.6
                                                                      
  *Persons*                                                          
   Lung                      40 405                  34 599 (86)     11.0
   Oral cavity and pharynx   6928                    4472 (65)       1.4
   Oesophagus                8528                    5583 (65)       1.8
   Stomach                   7043                    1565 (22)       0.5
   Liver                     3568                    819 (23)        0.3
   Pancreas                  8362                    2396 (29)       0.8
   Colon--rectum             39 911                  3235 (8)        1.0
   Larynx                    2184                    1726 (79)       0.5
   Cervix uteri              2693                    195 (7)         0.1
   Ovary                     6820                    177 (3)         0.1
   Bladder                   9282                    3403 (37)       1.1
   Kidney                    9061                    2181 (24)       0.7
   Leukaemia                 7840                    487 (6)         0.2
   All cancers               314 251                 60 837 (19.4)   19.4
